RxDoctor Payments Data

Frances West, MD

Pulmonary Disease · Philadelphia, PANPI 1750608790

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (29.7%), other and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Penumbra, Inc. at 28.0% of the total. Reporting peaked in 2024 at $6,435 and has fallen 76.0% since, to $1,546 in 2025.

$14,142in general payments, 2019–2025

Across 78 payments — averaging $181.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$4K
  • Exo Imaging, Inc.$4K
  • Inari Medical, Inc.$3K
  • Fujifilm Sonosite, Inc.$2K
  • Mindray DS USA, Inc.$219
  • Innova Vascular Inc.$160
  • plus $1K from 13 others
$25,000in research payments, 2019–2025

Across 1 payment — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$25K

What the payments were for

  • Consulting fees$4,20330%
  • Speaking & faculty fees$2,00014%
  • Travel & lodging$1,0387%
  • Food & beverage$3,35024%
  • Gifts$500%
  • Other$3,50025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.12$3,959
Exo Imaging, Inc.2$3,550
Inari Medical, Inc.15$3,497
Fujifilm Sonosite, Inc.9$1,619
Mindray DS USA, Inc.3$219
Innova Vascular Inc.1$160
Boston Scientific1$156
Philips North America LLC1$144
GSK6$134
Sanofi5$117
Regeneron Healthcare Solutions, Inc.4$115
AstraZeneca(2 entities)5$102
GE HealthCare1$97
Boehringer Ingelheim4$90
Genentech USA, Inc.4$81
Bayer2$42
Takeda Pharmaceuticals U.S.A., Inc.1$24
Stryker1$17
Electromed, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,142 in reported general payments places this provider in the 85th percentile of 703 pulmonary disease providers in Pennsylvania.

See all pulmonary disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$27,963
Medicare patients
63
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →